Advertisement
Singapore markets close in 33 minutes
  • Straits Times Index

    3,275.57
    -12.18 (-0.37%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,119.03
    +40.17 (+0.50%)
     
  • Bitcoin USD

    64,364.40
    +372.88 (+0.58%)
     
  • CMC Crypto 200

    1,389.52
    -7.01 (-0.50%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • Dow

    38,085.80
    -375.12 (-0.98%)
     
  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     
  • Gold

    2,359.20
    +16.70 (+0.71%)
     
  • Crude Oil

    83.87
    +0.30 (+0.36%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • FTSE Bursa Malaysia

    1,573.71
    +4.46 (+0.28%)
     
  • Jakarta Composite Index

    7,058.37
    -96.93 (-1.36%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Moderna and Other Coronavirus Vaccine Makers to Take Reduced Payments If Approval Milestones Not Met

Moderna and Other Coronavirus Vaccine Makers to Take Reduced Payments If Approval Milestones Not Met

If Moderna (NASDAQ: MRNA) and its peers take too long to get their current coronavirus vaccine candidates fully developed and approved, they could pay the price. The government is mandating that they meet ambitious targets for this. Moderna, for example, will receive $1.5 billion from the government if its MRNA-1273 candidate is approved for use by Jan. 31, 2021.